Position in ALNY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$6,832,778
-$1,168,982 QoQ
Shares Held
22,698
-6.1% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#219
of 786 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Eurizon Capital SGR S.p.A. holds $103,901,222 across 34 Biotechnology names. ALNY ranks #5 (6.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
82,582 | $41,020,956 | |
| 2 | INCY |
Incyte Corp
|
204,785 | $23,214,427 | |
| 3 | RPRX |
Royalty Pharma plc
|
256,636 | $14,389,580 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,467 | $9,644,293 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
22,698 | $6,832,778 | |
| 6 | INSM |
INSMED Inc
|
20,247 | $2,158,735 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
8,985 | $1,682,710 | |
| 8 | MRNA |
Moderna, Inc.
|
8,189 | $573,475 |
All Filings in ALNY
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,832,778 | 22,698 | Shares | Other | 2026-07-29 | |
| 2026-03-31 | $8,001,760 | 24,184 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $9,706,636 | 24,410 | Shares | Other | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||